Accueil › Annuaire des chercheurs › Steffen Borrmann
Steffen Borrmann
Affiliation : Kenya Medical Research Institute · KEMRI-Wellcome Trust Research Programme
- 30Publications (affiliation kényane)
Profil de recherche
Steffen Borrmann compte 30 publications référencées (2005–2018). Ses travaux paraissent principalement dans « PLoS ONE », « Antimicrobial Agents and Chemotherapy » et « PLoS Medicine ». Son article le plus cité, « Spread of Artemisinin Resistance in Plasmodium falciparum Malaria » (2014), a été cité 2205 fois. 2 de ces publications datent des trois dernières années d’activité. Ses travaux sont cosignés avec au moins 12 chercheurs, notamment dans des établissements de Royaume-Uni, États-Unis, Allemagne, Gabon.
C’est vous ? Faites connaître vos travaux
Créez gratuitement votre profil DzCademia et ajoutez vos articles : ils apparaîtront plus facilement sur Google et dans les assistants d’IA comme ChatGPT. Plus de personnes pourront vous lire et vous citer.
Créer mon profil gratuit Ajouter mes publicationsPublications (30)
- Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis
- Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis
- Novel approaches to whole sporozoite vaccination against malaria
- Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
- A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains
- A micro-epidemiological analysis of febrile malaria in Coastal Kenya showing hotspots within hotspots
- Dihydroartemisinin-Piperaquine vs. Artemether-Lumefantrine for First-Line Treatment of Uncomplicated Malaria in African Children: A Cost-Effectiveness Analysis
- Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in Kenya
- Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives
- PlasmoView: A Web-based Resource to Visualise Global Plasmodium falciparum Genomic Variation
- Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing
- Declining Responsiveness of Plasmodium falciparum Infections to Artemisinin-Based Combination Treatments on the Kenyan Coast
- Population Genetic Analysis of Plasmodium falciparum Parasites Using a Customized Illumina GoldenGate Genotyping Assay
- Induction of Antimalaria Immunity by Pyrimethamine Prophylaxis during Exposure to Sporozoites Is Curtailed by Parasite Resistance
- Targeting Plasmodium liver stages: better late than never
- Pharmacokinetic and Pharmacodynamic Characteristics of a New Pediatric Formulation of Artemether-Lumefantrine in African Children with Uncomplicated Plasmodium falciparum Malaria
- Natural Immunization Against Malaria: Causal Prophylaxis with Antibiotics
- The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem®) for acute uncomplicatedPlasmodium falciparummalaria
- Defining Clinical Malaria: The Specificity and Incidence of Endpoints from Active and Passive Surveillance of Children in Rural Kenya
- In Vitro Activities of Quinine and Other Antimalarials and pfnhe Polymorphisms in Plasmodium Isolates from Kenya
- Chloroquine resistance before and after its withdrawal in Kenya
- In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan Plasmodium falciparum Isolates and Polymorphisms in p fcrt and p fmdr1
- Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial
- Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria
- In Vitro Activity of Antifolate and Polymorphism in Dihydrofolate Reductase ofPlasmodium falciparumIsolates from the Kenyan Coast: Emergence of Parasites with Ile-164-Leu Mutation
- In Vivo and In Vitro Efficacy of Amodiaquine againstPlasmodium falciparumin an Area of Continued Use of 4‐Aminoquinolines in East Africa
- Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial
- Effects of Plasmodium falciparum Parasite Population Size and Patient Age on Early and Late Parasitological Outcomes of Antimalarial Treatment in Children
- Delayed parasite elimination in human infections treated with clindamycin parallels ‘delayed death’ of Plasmodium falciparum in vitro
- SHORT REPORT: PILOTING PAPERLESS DATA ENTRY FOR CLINICAL RESEARCH IN AFRICA
Revues de publication
- PLoS ONE × 6
- Antimicrobial Agents and Chemotherapy × 6
- PLoS Medicine × 2
- Malaria Journal × 2
- The Journal of Infectious Diseases × 2
- Vaccine × 1
Publications par année
- 20181
- 20171
- 20151
- 20144
- 20133
- 20121
- 20115
- 20104
- 20096
- 20082
Collaborations
Établissements partenaires : University of Oxford · Wellcome Trust · John Radcliffe Hospital · Boston Children's Hospital · Albert Schweitzer Hospital
Pays des co-auteurs : Royaume-Uni · États-Unis · Allemagne · Gabon
Co-auteurs
- Leah Mwai
- Alexis M. Nzila
- Kevin Marsh
- Steven M. Kiara
- Philip Galula Sasi
- Mahfudh M. Bashraheil
- Judy Peshu
- Elizabeth A Juma
- Brett S Lowe
- Steven Muriithi
- Abdirahman I. Abdi
- John Okombo
Données bibliographiques issues d’OpenAlex (base ouverte).
Pourquoi choisir DzCademia ?
Pour donner à vos travaux plus de chances d’être découverts et recommandés par les IA. Profils, articles et communications : donnez à votre recherche une présence publique structurée. Les métadonnées intégrées aident les moteurs de recherche et les assistants IA à identifier vos travaux et à comprendre leurs références.
Commenter avec Google
Connecte-toi avec Google pour commenter directement sur cette page.